De Keyser J
Department of Neurology, Academisch Ziekenhuis Vrije Universiteit Brussel, Belgium.
Neurochem Int. 1993 Feb;22(2):83-93. doi: 10.1016/0197-0186(93)90001-l.
Dopamine receptors in the human brain play an important role in the pathophysiology and treatment of psychosis and movement disorders. Pharmacological and biochemical studies, and more recently gene cloning techniques, have demonstrated that there are multiple receptors for dopamine in the brain. There is confusion in the literature as new subtypes (D3, D4 and D5 receptors) were classified according to unspecified criteria. At present, however, all subtypes of dopamine receptors that have been identified still fit in the traditional D1/D2 dopamine receptor classification scheme. In this article, a more hierarchical system of nomenclature is proposed and our insights into the distribution and localization of the dopamine receptor subtypes in human brain are summarized. Although the current status of the different subtypes of the D1 and D2 receptor families in human brain remains unclear, their discovery has created hope for the development of more efficacious and specific medicines with less side-effects.
人类大脑中的多巴胺受体在精神病和运动障碍的病理生理学及治疗中发挥着重要作用。药理学和生化研究,以及最近的基因克隆技术,都表明大脑中存在多种多巴胺受体。由于新的亚型(D3、D4和D5受体)是根据未明确的标准分类的,文献中存在混淆。然而,目前已鉴定出的所有多巴胺受体亚型仍符合传统的D1/D2多巴胺受体分类方案。本文提出了一个更具层次结构的命名系统,并总结了我们对人类大脑中多巴胺受体亚型分布和定位的见解。尽管人类大脑中D1和D2受体家族不同亚型的现状仍不明确,但它们的发现为开发更有效、副作用更小的特异性药物带来了希望。